CSJA:FRA
CSL ADR
30,40 €
arrow_upward
+1,33%(+0,40) 1D
11-ноя., 22:00:00 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSJA...
Open
29,60 €
High
30,40 €
Low
29,60 €
Mkt. cap
96,78 млд
Avg. vol.
0,00
Volume
0,00
52-wk high
43,40 €
52-wk low
12,70 €
No. of employees
29 миң
Open
29,60 €
High
30,40 €
Low
29,60 €
Mkt. cap
96,78 млд
Avg. vol.
0,00
Volume
0,00
52-wk high
43,40 €
52-wk low
12,70 €
No. of employees
29 миң
News stories
From web sources and news partners
Kalkine
·
20 саат мурун
CSL Limited Buys Back 44,235 Shares on 10 November 2026 Under $1.15 Billion Program
Kalkine
·
5 күн мурун
CSL Limited Buys Back 44,316 Shares on 6 November 2026 for A$8.93 Million
Profile
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
About CSL ADR
CEOPaul McKenzie
Employees29 миң
Founded1916
HeadquartersМельбурн, Виктория, Австралия
SectorHealth Care
Industry-
Websitecsl.com